Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Promotes anchorage-independent cell growth and tumor formation (By similarity).. Additionally we are shipping KIAA1524 Antibodies (72) and KIAA1524 Kits (9) and many more products for this protein.
Showing 4 out of 4 products:
Aberrant expression of cancerous inhibitor of protein phosphatase 2A (CIP2A) indicates poor prognosis and promotes EMT (show ITK Proteins) and metastasis.
CIP2A overexpression is associated with lung metastasis in colorectal cancer .
MycN (show MYCN Proteins)/CIP2A-mediated cell-fate bias may reflect a possible mechanism underlying early priming of some aggressive forms of neuroblastoma (show ARHGEF16 Proteins).
that CIP2A plays an important role in the carcinogenesis of endometrioid adenocarcinoma
CIP2A has higher expression in DDP (show TIMM8A Proteins)-resistant GC patients. DDP (show TIMM8A Proteins)-resistant GC patients with high CIP2A expression presented with poorer overall survival rates than those with low CIP2A expression.
High CIP2A expression is associated with laryngeal carcinoma.
High expression of CIP2A is associated with cisplatin resistant gastric cancer.
These data reveal that CIP2A is a crucial mediator of FN-induced bladder cancer cell proliferation via enhancing the stabilization of beta-catenin (show CTNNB1 Proteins).
confirmed the high mRNA and protein expression levels of CIP2A in hepatocellular carcinoma (HCC (show FAM126A Proteins)), and found high CIP2A mRNA expression level was associated with unfavorable overall and recurrence-free survival in patients with HCC (show FAM126A Proteins)
High CIP2A expression is associated with gemcitabine resistance in pancreatic cancer.
CIP2A acts as a scaffold for CEP192-mediated microtubule organizing center assembly by recruiting Plk1 and aurora A (show AURKA Proteins) during meiotic maturation in mouse oocytes
Knockdown of CIP2A by stable CIP2A siRNA transfection inhibited MDA-MB-231 cell proliferation, invasion, colony growth in vitro, and xenograft growth and metastasis in vivo of breast cancer in mice.
CIP2A as a hitherto unrecognized mediator of T-cell activation.
Downregulation of CIP2A suppresses cell proliferation and growth of nasopharyngeal carcinoma.
CIP2A strongly interacts with NEK2 (show NEK2 Proteins) during G2/M phase, thereby enhancing NEK2 kinase (show NEK2 Proteins) activity to facilitate centrosome separation in a PP1 (show PPP1CC Proteins)- and PP2A (show PPP2R2B Proteins)-independent manner.
Data show that CIP2A expression can be systematically inhibited without severe consequences to normal mouse development and viability may have clinical relevance regarding targeting of oncogenic CIP2A for future cancer therapies.
Loss of CIP2A in Myc (show MYC Proteins)-overexpressing neural progenitor cells significantly reduces the ability of Myc (show MYC Proteins) to increase self-renewal and proliferation.
Promotes anchorage-independent cell growth and tumor formation (By similarity).
cancerous inhibitor of PP2A
, p90 autoantigen
, protein CIP2A
, p90 autoantigen homolog
, protein CIP2A homolog
, CONSTANS interacting protein 2a
, hypothetical protein LOC100216050